The Journal of Immunology · 1982 · 68 citations · 0 references
Life SciencesCell BiologyImmunologyCell AdhesionCellular ImmunologyLeukocyte AdhesionLeukocyte RecruitmentLeukocyte TraffickingLymphatic AnatomyLymphocyte TraffickingLymphoid TissueCell Surface DisplayCell Surface GlycoproteinsCell Surface SpecializationsEndothelial Adhesion MoleculesLymph Node EntryLymph Node HomingLymph Node MicroenvironmentLymphatic Endothelial Cells
Abstract Rat thoracic duct lymphocytes (TDL) adhere specifically to high endothelial cell venules (HEV) when overlaid onto lymph node sections. Adhesion is blocked by pre-treating sections with an HEV binding inhibitory factor isolated from rat thoracic duct lymph. The idea that this factor is derived from lymphocyte surface molecules mediating HEV adhesion was investigated using rabbit anti-inhibitory factor Ig. This antibody labeled 70 to 80% of TDL (indirect immunofluorescence). Treatment of TDL with anti-inhibitor IgG, F(ab′)2, or Fab reduced their capacity to bind to HEV in LN sections by ~80% compared to cells treated with nonimmune rabbit Ig. In contrast, anti-inhibitor antibody did not affect binding when used to treat LN sections. Anti-inhibitor F(ab′)2 or Fab treatment also interfered with the entry of 51Cr-labeled TDL into LN of i.v. injected recipients. The concentration of radioactivity was reduced by about 70% in cervical and axillary LN and about 50% in mesenteric LN at 2 hr. Even though TDL enter Peyer’s patches (PP) via HEV, accumulation of radioactivity in this organ was not reduced by anti-inhibitor Ig; the antibody had no effect on the recovery of label in spleen, liver, lung, or blood. Similar findings were obtained with TDL-derived T cells and B cells, in that anti-inhibitor antibody reduced radioactivity in LN (cervical and axillary, about 70%, and mesenteric, 20 to 40%) but not in PP, spleen, liver, lung, and blood. Neither anti-thymocyte nor anti-Ig F(ab′)2 produced alterations in lymphocytes that inhibited TDL adherence to HEV in vitro or migration into LN in vivo. We conclude that specific high endothelial adherence molecules on recirculating lymphocytes are responsible for entry into LN, and we suggest that different molecules mediate their entry into PP and spleen.